查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790211

美國小分子藥物研發外包市場規模、佔有率和趨勢分析報告：按工作流程、服務、治療領域、最終用途和細分市場預測，2025 年至 2033 年

U.S. Small Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow, By Service, By Therapeutics Area, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國小分子藥物研發外包市場概況

美國小分子藥物研發外包市場規模預計在 2024 年為 15.2 億美元，預計到 2033 年將達到 34.7 億美元，2025 年至 2033 年的複合年成長率為 9.7%。市場受到研發支出增加、對早期研究活動的日益關注以及內部資源有限的生物技術公司的成長的推動。

此外，外包已成為製藥和生物技術公司的策略選擇，這些公司希望加快進度，降低固定間接成本，並在藥物化學、先導藥物最適化、ADME/PK 測試和 IND 授予活動等領域獲得專業知識。

人工智慧化合物設計、基於 CRISPR 的標靶驗證、高性能篩檢和 3D 細胞模型等創新技術正在改變藥物研發流程，委外研發機構(CRO) 能夠提供更有效率、更可預測的成果。此外，研發成本的上升、藥物開發需求的增加以及向虛擬製藥模式的轉變也為市場提供了支撐。此外，註冊臨床試驗的增加、小分子藥物核准率的提高、醫療技術的進步、正在研究的疾病數量的增加以及對新療法的迫切需求預計將推動市場發展。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國小分子藥物發現外包市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 臨床試驗量分析（2024年）
    • 各國臨床試驗總數
    • 各階段臨床試驗總數
    • 按研究設計分類的臨床試驗總數
    • 按主要治療領域分類的臨床試驗總數
  • 定價模式分析
  • 科技
  • 市場分析工具
    • 波特五力分析
    • PESTEL 與 SWOT 分析

第4章美國小分子藥物研發外包市場：工作流程估算與趨勢分析

  • 美國小分子藥物研發外包市場（依工作流程）：細分儀表板
  • 美國小分子藥物研發外包市場（依工作流程）：差異分析
  • 按工作流程，2021-2033 年
  • 目標識別與篩檢
  • 對象檢驗和功能資訊科學
  • 潛在客戶資格審查和候選人最佳化
  • 臨床前開發
  • 其他

第5章美國小分子藥物研發外包市場：按服務分類的估價與趨勢分析

  • 美國小分子藥物研發外包市場（按服務）：細分儀表板
  • 美國小分子藥物研發外包市場（按服務）：波動分析
  • 按服務分類，2021-2033 年
  • 化學服務
  • 生物服務

第6章：美國小分子藥物研發外包市場（依治療領域、估價與趨勢分析）

  • 美國小分子藥物研發外包市場（依治療領域）：細分儀表板
  • 美國小分子藥物研發外包市場（依治療領域）：波動分析
  • 依治療領域，2021-2033年
  • 呼吸系統
  • 疼痛和麻醉
  • 腫瘤學
  • 眼科
  • 血液學
  • 心血管系統
  • 內分泌
  • 胃腸道
  • 免疫調節
  • 抗感染
  • 中樞神經系統
  • 皮膚科
  • 泌尿生殖系統

第7章美國小分子藥物研發外包市場：依最終用途的估計與趨勢分析

  • 美國小分子藥物研發外包市場（依最終用途）：細分儀表板
  • 美國小分子藥物研發外包市場（依最終用途）：波動分析
  • 按應用，2021-2033 年
  • 製藥和生物技術公司
  • 學術機構

第8章 競爭態勢

  • 市場參與企業分類
    • 市場領導者
    • 新參與企業
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • Charles River Laboratories
    • Laboratory Corporation of America Holdings（Covance）
    • Albany Molecular Research（Curia）
    • Merck & Co., Inc.
    • QIAGEN
    • Eurofins
    • Evotec
    • GenScript BIoTech
    • Pharmaron
    • Syngene International
    • Dalton Pharma Services
    • Oncodesign
    • Jubilant Biosys
    • Domainex
    • Dr. Reddy Laboratories Ltd.
    • Pharmaron Beijing Co., Ltd.
    • TCG Lifesciences Pvt Ltd.

第9章 主要建議

Product Code: GVR-4-68040-687-1

U.S. Small Molecule Drug Discovery Outsourcing Market Summary

The U.S. small molecule drug discovery outsourcing market size was estimated at USD 1.52 billion in 2024 and is projected to reach USD 3.47 billion by 2033, growing at a CAGR of 9.7% from 2025 to 2033. Increasing R&D expenses, rising focus on early-stage research activities, and growing biotech companies with limited in-house resources drive the market.

Besides, outsourcing has emerged as a strategic option for pharmaceutical and biotech companies aiming to accelerate the timelines, lower fixed overhead costs, and gain access to specialized expertise in areas such as medicinal chemistry, hit-to-lead optimization, ADME/PK studies, and IND-enabling activities.

Innovations like AI-driven compound design, CRISPR-based target validation, high-throughput screening, and 3D cell models transform discovery processes, enabling contract research organizations (CROs) to provide more efficient and predictive results. Furthermore, rising R&D costs, increased demand for drug development, and a shift towards virtual pharmaceutical models support the market. In addition, an increase in registered clinical studies, a higher approval rate for small molecule drugs, advancements in medical technology, a rise in diseases being studied, and the urgent need for new treatments are anticipated to drive the market.

U.S. Small Molecule Drug Discovery Outsourcing Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. small molecule drug discovery outsourcing market report based on workflow, service, therapeutics area, and end use:

  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Others
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Chemistry Services
  • Biology Services
  • Therapeutics Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Respiratory system
  • Pain and Anesthesia
  • Oncology
  • Ophthalmology
  • Hematology
  • Cardiovascular
  • Endocrine
  • Gastrointestinal
  • Immunomodulation
  • Anti-infective
  • Central Nervous System
  • Dermatology
  • Genitourinary System
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology companies
  • Academic Institutes

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Workflow
    • 1.2.2. Service
    • 1.2.3. Therapeutics Area
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain-based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Small Molecule Drug Discovery Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for outsourcing services in drug development
      • 3.2.1.2. Technological advancements in drug discovery
      • 3.2.1.3. Rising shortening time-to-market pressures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Intellectual property (IP) and data security concerns
      • 3.2.2.2. Limited standardization and reproducibility
  • 3.3. Clinical Trials Volume Analysis, (2024)
    • 3.3.1. Total Number Of Clinical Trials By Country
    • 3.3.2. Total Number Of Clinical Trials, By Phase
    • 3.3.3. Total Number Of Clinical Trials, By Study Design
    • 3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
  • 3.4. Pricing Model Analysis
  • 3.5. Technology Landscape
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. U.S. Small Molecule Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

  • 4.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
  • 4.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
  • 4.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2021 - 2033 (USD Million)
  • 4.4. Target Identification & Screening
    • 4.4.1. Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Target Validation & Functional Informatics
    • 4.5.1. Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Lead Identification & Candidate Optimization
    • 4.6.1. Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Preclinical Development
    • 4.7.1. Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Small Molecule Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis

  • 5.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By Service: Segment Dashboard
  • 5.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By Service: Movement Analysis
  • 5.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 5.4. Chemistry Services
    • 5.4.1. Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Biology Services
    • 5.5.1. Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Small Molecule Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

  • 6.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
  • 6.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
  • 6.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics Area, 2021 - 2033 (USD Million)
  • 6.4. Respiratory system
    • 6.4.1. Respiratory System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Pain and Anesthesia
    • 6.5.1. Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Oncology
    • 6.6.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Ophthalmology
    • 6.7.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Hematology
    • 6.8.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Cardiovascular
    • 6.9.1. Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Endocrine
    • 6.10.1. Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Gastrointestinal
    • 6.11.1. Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.12. Immunomodulation
    • 6.12.1. Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.13. Anti-infective
    • 6.13.1. Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.14. Central Nervous System
    • 6.14.1. Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.15. Dermatology
    • 6.15.1. Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.16. Genitourinary System
    • 6.16.1. Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Small Molecule Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis

  • 7.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
  • 7.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By End Use: Movement Analysis
  • 7.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology companies
    • 7.4.1. Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Academic Institutes
    • 7.5.1. Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Company Market Share/Assessment Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. Charles River Laboratories
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Laboratory Corporation of America Holdings (Covance)
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Albany Molecular Research (Curia)
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Merck & Co., Inc.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. QIAGEN
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Eurofins
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Evotec
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. GenScript Biotech
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Pharmaron
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Syngene International
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Dalton Pharma Services
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Oncodesign
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Service Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Jubilant Biosys
      • 8.3.13.1. Company Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Service Benchmarking
      • 8.3.13.4. Strategic Initiatives
    • 8.3.14. Domainex
      • 8.3.14.1. Company Overview
      • 8.3.14.2. Financial Performance
      • 8.3.14.3. Service Benchmarking
      • 8.3.14.4. Strategic Initiatives
    • 8.3.15. Dr. Reddy Laboratories Ltd.
      • 8.3.15.1. Company Overview
      • 8.3.15.2. Financial Performance
      • 8.3.15.3. Service Benchmarking
      • 8.3.15.4. Strategic Initiatives
    • 8.3.16. Pharmaron Beijing Co., Ltd.
      • 8.3.16.1. Company Overview
      • 8.3.16.2. Financial Performance
      • 8.3.16.3. Service Benchmarking
      • 8.3.16.4. Strategic Initiatives
    • 8.3.17. TCG Lifesciences Pvt Ltd.
      • 8.3.17.1. Company Overview
      • 8.3.17.2. Financial Performance
      • 8.3.17.3. Service Benchmarking
      • 8.3.17.4. Strategic Initiatives

Chapter 9. Key Recommendations

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 5 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 6 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 7 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 U.S. small molecule drug discovery outsourcing market dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. Small molecule drug discovery outsourcing market: workflow outlook and key takeaways
  • Fig. 20 U.S. small molecule drug discovery outsourcing market: workflow movement analysis
  • Fig. 21 Target identification & screening market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Target validation & functional informatics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Lead identification & candidate optimization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Preclinical development market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Other market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. small molecule drug discovery outsourcing market: Service outlook and key takeaways
  • Fig. 27 U.S. small molecule drug discovery outsourcing market: Service movement analysis
  • Fig. 28 Chemistry services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Biology services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. small molecule drug discovery outsourcing market: therapeutics area outlook and key takeaways
  • Fig. 31 U.S. small molecule drug discovery outsourcing market: therapeutics area movement analysis
  • Fig. 32 Respiratory system market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Pain and anesthesia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Ophthalmology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Hematology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Cardiovascular market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Endocrine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Gastrointestinal market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Immunomodulation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Anti-infective market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Central nervous system market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Dermatology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Genitourinary system market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 U.S. small molecule drug discovery outsourcing market: End use outlook and key takeaways
  • Fig. 46 U.S. small molecule drug discovery outsourcing market: End use movement analysis
  • Fig. 47 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Academic institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key company categorization
  • Fig. 50 Service heat map analysis
  • Fig. 51 Strategic framework